JOURNAL ARTICLE
Comparison of fluid warmer performance during simulated clinical conditions.
Canadian Journal of Anaesthesia 1995 July
The study evaluated the warming ability and flow rates associated with four fluid warming devices during pressure driven infusion and during wide open gravity driven roller clamp infusion. Warmers tested were the Astotherm, Flotem IIe, Level 1 System 250 and a modified cardioplegia heat exchanger. Fluids tested were crystalloid, red cells diluted with 200 ml, 0.9% saline, and undiluted red cells. The volume of fluid and outlet temperatures (point where i.v. tubing would be attached to the patient) were measured for each fluid and compared among warmers for each flow rate condition. For pressure driven infusion of red cells and crystalloid, the System 250, and modified heat exchanger delivered warmer fluids (33-35 degrees C) at higher flow rates (160-740 ml.min-1) than the Astotherm and Flotem (23-31 degrees C, 44-268 ml.min-1, P < 0.05). For gravity driven infusion, the System 250 delivered the warmest fluids (33-36 degrees C, P < 0.05) compared with the modified heat exchanger (29-35 degrees C), Astotherm (26-32 degrees C) and Flotem (26-27 degrees C). In conclusion, the modified heat exchanger and System 250 were moderately effective (outlet temperature > 32 degrees C) in warming crystalloid and red cells at pressure driven flow rates. Only the System 250 warmed red cells > 35 degrees C at gravity driven flow rates. The Flotem and Astotherm were not effective in warming rapidly infused solutions. None of the warmers tested was able to deliver fluids at normothermia (> 36.5 degrees C).
Full text links
Trending Papers
Migraine.Annals of Internal Medicine 2023 January 11
How to diagnose iron deficiency in chronic disease: A review of current methods and potential marker for the outcome.European Journal of Medical Research 2023 January 10
Long COVID: major findings, mechanisms and recommendations.Nature Reviews. Microbiology 2023 January 14
Diabetic kidney disease in type 2 diabetes: a consensus statement from the Swiss Societies of Diabetes and Nephrology.Swiss Medical Weekly 2023 January 7
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app